title: Is the Antiglobulin Test a Good Marker for Predicting the Development of Hemolytic Disease of the Newborn in ABO Incompatibility?
authors.affiliation: Department of Pediatrics-Neonatology, Firat University School of Medicine, Elazig, Turkey. Electronic address: dr1mustafa@hotmail.com.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Aydin
authors.affiliation: Department of Pediatrics-Neonatology, Firat University School of Medicine, Elazig, Turkey.
authors.forename: Ugur
authors.initials: U
authors.lastname: Deveci
authors.affiliation: Department of Pediatrics-Neonatology, Firat University School of Medicine, Elazig, Turkey.
authors.forename: Aysen
authors.initials: A
authors.lastname: Orman
authors.affiliation: Department of Pediatrics-Neonatology, Firat University School of Medicine, Elazig, Turkey.
authors.forename: Erdal
authors.initials: E
authors.lastname: Taskin
mesh_terms: D000017:ABO Blood-Group System; D015415:Biomarkers; D001787:Blood Group Incompatibility; D003298:Coombs Test; D004899:Erythroblastosis, Fetal; D006801:Humans; D007231:Infant, Newborn
chemical_list: D000017:ABO Blood-Group System; D015415:Biomarkers